Literature DB >> 14160151

RADIOACTIVE ISOTOPES FOR ADJUVANT CANCER THERAPY; ANIMAL EXPERIMENTATION AND PRELIMINARY RESULTS IN HUMAN APPLICATION.

I M ARIEL.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; CARCINOMA, BROWN-PEARCE; CHILD; CLINICAL RESEARCH; EXPERIMENTAL LAB STUDY; MECHLORETHAMINE; NEOPLASM RADIOTHERAPY; RABBITS; SURGERY, OPERATIVE; YTTRIUM ISOTOPES

Mesh:

Substances:

Year:  1964        PMID: 14160151     DOI: 10.1001/archsurg.1964.01320020008002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


× No keyword cloud information.
  5 in total

Review 1.  Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Authors:  Aaron K T Tong; Yung Hsiang Kao; Chow Wei Too; Kenneth F W Chin; David C E Ng; Pierce K H Chow
Journal:  Br J Radiol       Date:  2016-03-24       Impact factor: 3.039

Review 2.  Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.

Authors:  Linzi Arndt Webster; Alexander Villalobos; Bill S Majdalany; Zachary L Bercu; Ripal T Gandhi; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

3.  Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases.

Authors:  R Cianni; C Urigo; E Notarianni; A Saltarelli; A D'Agostini; M Iozzino; T Dornbusch; E Cortesi
Journal:  Radiol Med       Date:  2010-01-20       Impact factor: 3.469

4.  Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy.

Authors:  Yvonne Nadine Fahmueller; Dorothea Nagel; Ralf-Thorsten Hoffmann; Klaus Tatsch; Tobias Jakobs; Petra Stieber; Stefan Holdenrieder
Journal:  BMC Cancer       Date:  2012-01-04       Impact factor: 4.430

5.  Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.

Authors:  Seza A Gulec; Geraldine Mesoloras; William A Dezarn; Patrick McNeillie; Andrew S Kennedy
Journal:  J Transl Med       Date:  2007-03-14       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.